Skip to main content
. Author manuscript; available in PMC: 2009 Jan 1.
Published in final edited form as: Int J Biochem Cell Biol. 2007 Sep 6;40(3):484–495. doi: 10.1016/j.biocel.2007.08.016

Figure 4.

Figure 4

(A) Western Blot analysis confirmed this difference between AdTGF-β1 and -β3 seven days after administration of AdTGF-b1, b3 and AdDL by detection of more TGF-βRI (ALK-5) and TGF-βRII protein in rat lung homogenate (p<0.01 as quantified by band densitometry) (B) Smad-independent pathways were investigated by Western Blots and showed a trend to lower activation levels in the p42/44 and the Akt pathways in AdTGF-β1 treated lungs compared to controls and AdTGF-β3 (bands represent different animals, n=3).